The report states Aequs' board approved a Rs 650 crore equity infusion to expand capacity in aerospace and consumer business and support its borrowing programme.
Read this note →Aequs Limited
NSE AEQUS BSE 544634 INE947N01017
0 filings · 0 analysed
236.20
+56.12%
over 5 years
-
The report states Aequs' board approved a Rs 650 crore equity infusion to expand capacity in aerospace and consumer business and support its borrowing programme.
-
The report says Aequs's board approved a preferential issue of up to 2.8 crore warrants to a promoter group member, aggregating to approximately Rs 650 crore.
-
The factsheet discloses Aequus as an unhedged holding at 3.89% of NAV.
Prices from Yahoo Finance, NSE close, delayed — indicative only, not for dealing. Solid markers sit on the exchange's own timestamp.
What the desks said
The report says Aequs's board approved a preferential issue of up to 2.8 crore warrants to a promoter group member, aggregating to approximately Rs 650 crore.
Read this note →The factsheet discloses Aequus as an unhedged holding at 3.89% of NAV.
Read this note →Announcement timeline
No filings stored for this company yet.
Never miss the next one.
Orivam emails what the research desks published each trading morning, attributed and linked to the original notes. Free.
Get the daily brief